Search results

  1. Neutropenic sepsis

    Everything NICE has said on preventing, identifying and managing neutropenic sepsis in children, young people and adults in an interactive flowchart

  2. NICE chairman Sharmila Nebhrajani begins her new role

    NICE is delighted to announce that today (26 May 2020) Sharmila Nebhrajani, OBE, has taken up her position as its new chairman following her appointment by the Secretary of State for Health and Social Care and an independent open recruitment process.

  3. Hypertension in pregnancy

    Everything NICE has said on diagnosing and managing hypertension in pregnancy in an interactive flowchart

  4. Sunlight exposure: risks and benefits

    Everything NICE has said on how to communicate the risks and benefits of natural sunlight exposure in an interactive flowchart

  5. Transition from children's to adults' services

    Everything NICE has said on the transition from children's to adults' services for young people in health or social care in an interactive flowchart

  6. Acute upper gastrointestinal bleeding

    Everything NICE has said on risk assessment and management of acute upper gastrointestinal bleeding in people 16 years and older in an interactive flowchart

  7. Multimorbidity

    Everything NICE has said on optimising care for people with 2 or more long-term health conditions in an interactive flowchart

  8. Managing medicines in care homes

    Everything NICE has said on systems and processes for managing medicines in care homes in an interactive flowchart

  9. Metastatic spinal cord compression

    Everything NICE has said on detecting and managing metastatic spinal cord compression in adults with cancer in an interactive flowchart

  10. Spasticity in children and young people

    Everything NICE has said on managing spasticity and co-existing motor disorders in children and young people in an interactive flowchart

  11. NICE publishes new COVID-19 guidelines on cystic fibrosis, chronic obstructive pulmonary disease (COPD) and dermatological conditions treated with drugs affecting the immune response

    NICE has today (9 April 2020) published 3 new rapid guidelines on the care of patients with suspected and confirmed COVID-19, and in patients without COVID-19. The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.

  12. Musculoskeletal conditions

    Everything NICE has said on musculoskeletal conditions in an interactive flowchart

  13. Respiratory conditions

    Everything NICE has said on respiratory conditions in an interactive flowchart

  14. Osteoporosis

    Everything NICE has said on assessing the risk of, preventing and treating osteoporotic fragility fractures in adults in an interactive flowchart

  15. Head injury

    Everything NICE has said on triage, assessment, investigation and management of head injury in infants, children and adults in an interactive flowchart

  16. Dementia

    Everything NICE has said on assessment, management and support for people living with dementia and Alzheimer's disease and their carers in an interactive flowchart

  17. Structural heart defects

    Everything NICE has said on structural heart defects in an interactive flowchart

  18. Eating disorders

    Everything NICE has said on identifying and managing eating disorders in people 8 years and over in an interactive flowchart

  19. NICE publishes first rapid COVID-19 guidelines

    New guidelines cover the management of patients in critical care, the management of patients who are having kidney dialysis and the management of patients who are receiving systemic anticancer treatments.

  20. NICE to produce rapid COVID-19 guidelines

    NICE has today (20 March 2020) announced that it is developing a series of rapid guidelines with NHS England/Improvement on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19, in a number of clinical areas.

  21. The percentage of patients with a new diagnosis of depression or anxiety and a FAST score of ≥3 or AUDIT-C score of ≥5 in the preceding 12 months, who have received brief intervention to help them reduce their alcohol related risk within 3 months of the score being recorded.

    The percentage of patients with a new diagnosis of depression or anxiety and a FAST score of ≥3 or AUDIT-C score of ≥5 in the preceding 12 months, who